Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mechanisms of statin‐induced new‐onset diabetes
Maryam Paseban, Alexandra E. Butler, Amirhossein Sahebkar
Journal of Cellular Physiology (2019) Vol. 234, Iss. 8, pp. 12551-12561
Closed Access | Times Cited: 45

Showing 1-25 of 45 citing articles:

Regulation of cholesterol homeostasis in health and diseases: from mechanisms to targeted therapeutics
Yajun Duan, Ke Gong, Suowen Xu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 233
Feeding induces cholesterol biosynthesis via the mTORC1–USP20–HMGCR axis
Xiao-Yi Lu, Xiongjie Shi, Ao Hu, et al.
Nature (2020) Vol. 588, Iss. 7838, pp. 479-484
Closed Access | Times Cited: 184
Sex- and Gender-Based Pharmacological Response to Drugs
Franck Mauvais‐Jarvis, Heiner K. Berthold, Ilaria Campesi, et al.
Pharmacological Reviews (2021) Vol. 73, Iss. 2, pp. 730-762
Open Access | Times Cited: 135
Statin Treatment-Induced Development of Type 2 Diabetes: From Clinical Evidence to Mechanistic Insights
Unai Galicia-García, Shifa Jebari, Asier Larrea‐Sebal, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 13, pp. 4725-4725
Open Access | Times Cited: 119
Cholesterol metabolism, pancreatic β-cell function and diabetes
Carla Perego, Lorenzo Da Dalt, Angela Pirillo, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2019) Vol. 1865, Iss. 9, pp. 2149-2156
Open Access | Times Cited: 103
Molecular targets of statins and their potential side effects: Not all the glitter is gold
Kush K. Patel, Viren S Sehgal, Khosrow Kashfi
European Journal of Pharmacology (2022) Vol. 922, pp. 174906-174906
Open Access | Times Cited: 43
Pleiotropic use of Statins as non-lipid-lowering drugs
Qijia Zhang, Jianlong Dong, Ze Yu
International Journal of Biological Sciences (2020) Vol. 16, Iss. 14, pp. 2704-2711
Open Access | Times Cited: 53
Modulatory effects of statins on the autophagy: A therapeutic perspective
Milad Ashrafizadeh, Zahra Ahmadi, Tahereh Farkhondeh, et al.
Journal of Cellular Physiology (2019) Vol. 235, Iss. 4, pp. 3157-3168
Closed Access | Times Cited: 46
Synthesis, Structural Studies, and α-Glucosidase Inhibitory, Antidiabetic, and Antioxidant Activities of 2,3-Dihydroquinazolin-4(1H)-ones Derived from Pyrazol-4-carbaldehyde and Anilines
Alireza Barmak, Khodabakhsh Niknam, Gholamhossein Mohebbi
ACS Omega (2019) Vol. 4, Iss. 19, pp. 18087-18099
Open Access | Times Cited: 45
The effects of statins on mitochondria – the current state of knowledge
Małgorzata Belczyk, Małgorzata Knapik-Czajka, Anna Gawędzka, et al.
Farmacja Polska (2025) Vol. 80, Iss. 8, pp. 579-587
Open Access
Probiotic Effects of Lactobacillus fermentum ZJUIDS06 and Lactobacillus plantarum ZY08 on Hypercholesteremic Golden Hamsters
Dongting Yang, Wentao Lyu, Ziyi Hu, et al.
Frontiers in Nutrition (2021) Vol. 8
Open Access | Times Cited: 32
Modulation of microRNAs by aspirin in cardiovascular disease
Maryam Paseban, Reyhaneh Moradi Marjaneh, Maciej Banach, et al.
Trends in Cardiovascular Medicine (2019) Vol. 30, Iss. 5, pp. 249-254
Open Access | Times Cited: 31
The Pleiotropic Effects of Lipid-Modifying Interventions: Exploring Traditional and Emerging Hypolipidemic Therapies
Dimitris Kounatidis, Nikolaοs Tentolouris, Natalia G. Vallianou, et al.
Metabolites (2024) Vol. 14, Iss. 7, pp. 388-388
Open Access | Times Cited: 3
IL-1β and Statin Treatment in Patients with Myocardial Infarction and Diabetic Cardiomyopathy
Luca Liberale, Federico Carbone, Camici, et al.
Journal of Clinical Medicine (2019) Vol. 8, Iss. 11, pp. 1764-1764
Open Access | Times Cited: 28
Statin use and safety concerns: an overview of the past, present, and the future
Rubina Mulchandani, Tanica Lyngdoh, Ashish Kumar Kakkar
Expert Opinion on Drug Safety (2020) Vol. 19, Iss. 8, pp. 1011-1024
Closed Access | Times Cited: 22
A novel chemically engineered multifunctional statin conjugate as self-assembled nanoparticles inhibiting bile acid transporters
Kyeong-Ju Lee, Yoon-Mi Lee, Seong-Bin Yang, et al.
Journal of Controlled Release (2024) Vol. 372, pp. 885-900
Closed Access | Times Cited: 2
Safety of Proprotein Convertase Subtilisin/Kexin Type 9 Monoclonal Antibodies in Regard to Diabetes Mellitus: A Systematic Review and Meta-analysis of Randomized Controlled Trials
Qiwen Chen, Guodong Wu, Chuang Li, et al.
American Journal of Cardiovascular Drugs (2019) Vol. 20, Iss. 4, pp. 343-353
Closed Access | Times Cited: 20
Diabetic cardiomyopathy and inflammation: development of hostile microenvironment resulting in cardiac damage
Edoardo Elia, Stefano Ministrini, Federico Carbone, et al.
Minerva Cardiology and Angiology (2022) Vol. 70, Iss. 3
Closed Access | Times Cited: 11
Cholesterol Paradox in Older People with Type 2 Diabetes Mellitus Regardless of Lipid-Lowering Drug Use: A Cross-Sectional Cohort Study
Tzu-Yuan Wang, Wei‐Lun Chang, Cheng‐Yu Wei, et al.
Nutrients (2023) Vol. 15, Iss. 14, pp. 3270-3270
Open Access | Times Cited: 6
Statin-specific inhibition of Rab-GTPase regulates cPKC-mediated IKs internalization
Elsa Ronzier, Xiaorong Xu Parks, Haani Qudsi, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 18
Real-World Effectiveness of Statin Therapy in Adult Asthma
ChulHyoung Park, Jae-Hyuk Jang, Chungsoo Kim, et al.
The Journal of Allergy and Clinical Immunology In Practice (2023) Vol. 12, Iss. 2, pp. 399-408.e6
Closed Access | Times Cited: 5
Statin-induced new onset of diabetes in dyslipidemic patients: a retrospective study
Roshna Roy, Architha Ajithan, Anisa Joseph, et al.
Postgraduate Medicine (2019) Vol. 131, Iss. 6, pp. 383-387
Closed Access | Times Cited: 11
Fixed‐dose combination of amlodipine and atorvastatin improves clinical outcomes in patients with concomitant hypertension and dyslipidemia
Chia‐Pin Lin, Ying‐Chang Tung, Fu‐Chih Hsiao, et al.
Journal of Clinical Hypertension (2020) Vol. 22, Iss. 10, pp. 1846-1853
Open Access | Times Cited: 10
Electroacupuncture regulates hepatic cholesterol synthesis by HMGCR deubiquitination in rats
Shuwen Jin, Yongli Han, Xiaoli Pan, et al.
Heliyon (2023) Vol. 9, Iss. 10, pp. e21005-e21005
Open Access | Times Cited: 3
Effect of Ginkgo biloba extract on pharmacology and pharmacokinetics of atorvastatin in rats with hyperlipidaemia
Qingqing Wang, Zihou Liu, Rui Wang, et al.
Food & Function (2023) Vol. 14, Iss. 7, pp. 3051-3066
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top